Richard Gonzalez of AbbVie, and Daniel Welch of InterMune: Drop your legal action blocking access to EMA clinical trial data
  • Petitioned Richard Gonzalez, c/o Gregory Miley

This petition was delivered to:

Group Head, External Communications, AbbVie
Richard Gonzalez, c/o Gregory Miley
VP Corporate Communications
Daniel Welch, c/o Jim Goff

Richard Gonzalez of AbbVie, and Daniel Welch of InterMune: Drop your legal action blocking access to EMA clinical trial data

    1. David Healy
    2. Petition by

      David Healy

      Cardiff Wales, United Kingdom

Let us see Drug Data! Drug hazards are not “trade secrets”!

Drug companies maximize the sales of new drugs by hyping their benefits while downplaying significant risks. In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American, and European researchers and researchers around the world as a major step towards drug safety.

This process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.

AbbVie and InterMune have filed suit to deny access to the data from their trials on the benefits and harms of these drugs, claiming these vital facts are “trade secrets” whose release would harm their profits. Their action has led to the shutdown of the entire public-access program, leaving millions of patients worldwide, and their doctors, in the dark.

We call on AbbVie and InterMune to drop their European Union lawsuit and release all patient level data on Humira, Esbriet and their other products. Vital data on drug safety should never be hidden as a “trade secret.” By copying this petition to President Barack Obama and members of his Cabinet we call on them to ensure that meaningful public access to clinical trial data becomes the policy of the FDA and is written into any international trade agreements governing the sale of prescription drugs and devices.

Copies to:
President Barack Obama;
Margaret Hamburg, M.D., Commissioner, Food & Drug Administration;
Secretary General Ban Ki Moon, United Nations;
World Health Organization Director Dr Margaret Chan.

Richard Gonzalez, c/o Gregory Miley, Group Head, External Communications, AbbVie
Daniel Welch, c/o Jim Goff, VP Corporate Communications
Please drop your legal action blocking access to EMA clinical trial data.

[Your name]

Recent signatures


    1. Reached 5,000 signatures


    Reasons for signing

    • Daniel Burdick SPRINGFIELD, OR
      • 8 months ago

      That the truth being available for the public and prescribing physicians of the information from clinical drug trials and the harms that the drugs can cause may affect the sales profit from the products makes perhaps sense from the perspective of those tying to profit -- though it certainly does not from the perspective of those who might actually use the drug product and the government.

      People need government to do oversight, investigation and legislation to control industries.

      People who would take the drug products and Doctors who would prescribe them need to know the actual truth and not just be told whatever the company Public Relation's people think will be best to package the product as being.

    • Helen Weidner BASTROP, TX
      • 8 months ago

      I am getting old. I use no drugs. I am terrified of landing in a hospital or nursing home where someone else plies me with drugs they don't know the whole truth about! The only reliable science is transparent science.

    • Ann Fonfa DELRAY BEACH, FL
      • 8 months ago

      There are NO trade secrets, only 'secrets' kept from the Patient population (and Advocates)!

    • Kenneth Larsen ARLINGTON, MA
      • 8 months ago

      The public welfare and health take precedence over corporate gain.

      • 8 months ago

      How much did it cost to buy their souls?


    Develop your own tools to win.

    Use the API to develop your own organizing tools. Find out how to get started.